Cigna Group (NYSE:CI) Releases Earnings Results, Beats Expectations By $0.46 EPS

Key Points

• Cigna reported quarterly EPS of $7.98, beating estimates by $0.46, while revenue of $73.79 billion also topped forecasts and rose 5.6% year over year.
• The company raised its 2026 adjusted EPS outlook to at least $30.60 and reiterated long-term EPS growth targets of 10%–14%; its productivity program aims to deliver $3 billion in gross run-rate savings by 2030.
• Management expects pressure on pharmacy benefit services earnings in 2027 from rebate compression and reduced employer coverage of GLP-1 weight-loss drugs.

Cigna Group (NYSE:CI - Get Free Report) released its quarterly earnings results on Thursday. The health services provider reported $7.98 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.52 by $0.46, Zacks reports. The business had revenue of $73.79 billion during the quarter, compared to analyst estimates of $72.64 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%. Cigna Group's revenue for the quarter was up 5.6% on a year-over-year basis. During the same quarter in the previous year, the company posted $7.83 earnings per share.

Here are the key takeaways from Cigna Group's conference call:

• Positive Sentiment: Cigna reported third-quarter adjusted revenue of $73.8 billion and adjusted EPS of $7.98, and raised its 2026 adjusted EPS outlook to at least $30.60.
• Positive Sentiment: Specialty and Care Services earnings grew 15% year over year, supported by specialty pharmacy and distribution capabilities and strong adoption of lower-cost biosimilars and generics. Cigna Healthcare earnings also grew 15%, with medical costs elevated but stable and in line with pricing assumptions.
• Negative Sentiment: Evernorth Pharmacy Benefit Services faces 2027 pressure from industry-wide rebate compression and fewer employers covering GLP-1 drugs for weight loss; management expects PBS earnings to decline by a single-digit percentage. Signature adoption is expected to broaden in 2028, after the Cigna Healthcare fully insured launch in 2027.
• Positive Sentiment: Management expects at least 10% adjusted EPS growth in 2027 from an approximately $30 run-rate base, which reflects the ACA exchange exit and an estimated $200 million headwind. It also reaffirmed its long-term 10%–14% EPS growth framework and at least $45 of adjusted EPS by 2030.
• Positive Sentiment: Cigna expects its Accelerate to One modernization and productivity program to generate $3 billion in gross run-rate savings by 2030, with some savings reinvested in the business and some contributing to results.

Cigna Group Stock Down 1.2%

Cigna Group stock traded down $3.74 during midday trading on Thursday, hitting $301.67. 2,769,129 shares of the company's stock were exchanged, compared to its average volume of 1,519,686. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76. Cigna Group has a 12 month low of $255.53 and a 12 month high of $318.05. The firm has a 50-day moving average of $285.48 and a two-hundred day moving average of $282.05. The company has a market cap of $79.71 billion, a PE ratio of 9.70, a P/E/G ratio of 1.03 and a beta of 0.25.

Cigna Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 17th. Investors of record on Thursday, December 3rd will be paid a $1.56 dividend. The ex-dividend date of this dividend is Thursday, December 3rd. This represents a $6.24 dividend on an annualized basis and a yield of 2.1%. Cigna Group's dividend payout ratio is 25.82%.

Key Headlines Impacting Cigna Group

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Adjusted earnings were $7.98 per share, ahead of analyst expectations, while revenue rose 6% year over year to about $73.7 billion. Strength in Cigna Healthcare and a favorable drug mix supported results. Article: Cigna Q3 Earnings Top Estimates on Cigna Healthcare Strength
• Positive Sentiment: Management raised its 2026 adjusted earnings outlook to at least $30.60 per share. The company also outlined long-term targets of 10%–14% adjusted EPS growth and about $50 billion in cumulative operating cash flow through 2030, alongside a $3 billion modernization and productivity initiative. Article: The Cigna Group Reports Strong Third Quarter 2026 Results, Raises 2026 Outlook
• Negative Sentiment: Reported GAAP net income fell to $1.4 billion from $1.87 billion a year earlier, and Cigna’s planned exit from ACA marketplace business is nearing. These factors may temper the reaction to the adjusted earnings beat and higher outlook. Article: Cigna raises financial outlook as ACA exit nears

Analysts Set New Price Targets

A number of brokerages have recently issued reports on CI. Wall Street Zen cut shares of Cigna Group from a "buy" rating to a "hold" rating in a research note on Saturday, October 31st. Royal Bank Of Canada reiterated an "outperform" rating and set a $337.00 target price on shares of Cigna Group in a research report on Thursday, October 1st. Guggenheim lifted their price target on Cigna Group from $338.00 to $361.00 and gave the stock a "buy" rating in a research report on Friday, July 31st. Robert W. Baird set a $362.00 price target on Cigna Group in a research note on Friday, July 31st. Finally, Evercore began coverage on shares of Cigna Group in a research report on Wednesday, September 9th. They issued an "in-line" rating and a $290.00 price objective for the company. Fourteen equities research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $336.40.

Insider Transactions at Cigna Group

In other news, insider Everett Neville sold 617 shares of the business's stock in a transaction dated Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total value of $175,258.85. Following the completion of the sale, the insider owned 5,053 shares in the company, valued at approximately $1,435,304.65. The trade was a 10.88% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole Jones sold 2,677 shares of the business's stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total transaction of $748,515.97. Following the completion of the transaction, the insider directly owned 25,880 shares of the company's stock, valued at $7,236,306.80. This trade represents a 9.37% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.60% of the company's stock.

Cigna Group Company Profile

The Cigna Group NYSE: CI is a global health services company that provides insurance coverage, health care benefits and related services. Its operations are primarily organized through Cigna Healthcare, which offers medical, pharmacy, dental, behavioral health and other benefit programs to employers, government organizations and individuals, primarily in the United States.

The company also operates Evernorth Health Services, a health services platform that includes pharmacy benefit management, specialty pharmacy, care management and health-care delivery capabilities.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.